We are aware of an issue causing the title of some ARTG entries to disappear. We are investigating as a priority and hope to have this resolved as soon as possible.
KEYTRUDA Merck Sharp & Dohme (Australia) Pty Ltd
Product name
KEYTRUDA
Accepted date
Jul-2024
Active ingredients
pembrolizumab
Proposed indication
For the treatment of recurrent locally advanced or metastatic Merkel cell carcinoma.
Application type
C (new indication)
Publication date
Jul-2024